Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Johnson & Johnson Q2 Earnings

  Johnson & Johnson (NYSE:JNJ) reported its Q2 earnings results on Tuesday, July 19, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
July 19, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Johnson & Johnson (NYSE:JNJ) reported its Q2 earnings results on Tuesday, July 19, 2022 at 06:45 AM.

Here’s what investors need to know about the announcement.

Earnings

Johnson & Johnson beat estimated earnings by 0.78%, reporting an EPS of $2.59 versus an estimate of $2.57.

Revenue was up $699.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 0.44% increase in the share price the next day.

Here’s a look at Johnson & Johnson’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 2.61 2.12 2.36 2.27
EPS Actual 2.67 2.13 2.60 2.48
Revenue Estimate 23.67B 25.29B 23.74B 22.19B
Revenue Actual 23.43B 24.80B 23.34B 23.32B

To track all earnings releases for Johnson & Johnson visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Imax Reports Better-Than-Expected Q1 Results

By Erica Kollmann
April 25, 2:29 PM
Imax reported quarterly earnings of 15 cents per share which beat the analyst consensus estimate of 10 cents by 50%. Quarterly sales of $79.12 million beat the analyst consensus estimate of $78.18 million by 1.21%. The company reported 15 Imax system installations in the first quarter, up 67% year-over-year and 17 signings for new and upgraded IMAX systems worldwide year-to-date.

IMAX